JPRN-UMIN000047198
Recruiting
未知
Development of biomarker predicting the response of immunotherapy for patients with urothelial cancer using urine miRNA - Development of precision medicine for patients with urothelial cancer
Conditionsurothelial cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- urothelial cancer
- Sponsor
- Tokyo Medical University
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1, patients with history of using immunotherapy for urothelial or non\-urothelial carcinoma before the registration of this study. 2, patients with other cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Development of new biomarker to predict the response of anti-cancer drugs for lung cancerJPRN-UMIN000024176Kochi Medical school, Kochi University200
Not yet recruiting
Not Applicable
Identifying factors that help predict improvement with deep brain stimulation (a surgical treatment) for obsessive-compulsive disorderHealth Condition 1: F422- Mixed obsessional thoughts and actsCTRI/2020/03/024131Wellcome Trust DBT India Alliance
Completed
Not Applicable
Identification of biomarkers that predict responsiveness to Dupilumab among severe asthmaJPRN-UMIN000041915ational Hospital Organization Tokyo National Hospital15
Completed
Not Applicable
Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung canceron-small-cell lung cancerJPRN-UMIN000022505Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
Completed
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000010140Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences216